A novel hemizygous mutation of MAMLD1 in a patient with 46,XY complete gonadal dysgenesis

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • Inge Lore Ruiz-Arana - , Humboldt University of Berlin (Author)
  • Angela Hübner - , Department of Paediatrics (Author)
  • Cigdem Cetingdag - , Humboldt University of Berlin (Author)
  • Heiko Krude - , Humboldt University of Berlin (Author)
  • Annette Grüters - , Humboldt University of Berlin (Author)
  • Maki Fukami - , National Center for Child Health and Development (Author)
  • Heike Biebermann - , Humboldt University of Berlin (Author)
  • Birgit Köhler - , Humboldt University of Berlin (Author)

Abstract

MAMLD1 is suggested to play a role in the development of 46,XY disorders of sexual development (46,XY DSD). So far, mutations in this gene have been detected in several cases of hypospadias with normal testosterone levels at birth. From in vitro studies it was concluded that Mamld1 might transiently affect testosterone synthesis during genital development. We describe the first MAMLD1 mutation in a 46,XY patient with complete gonadal dysgenesis. The novel MAMLD1 missense mutation (p.P677L) results in a severely reduced transactivation in vitro of the promoter of the MAMLD1 target gene HES3/Hes3. However, as knowledge about the functional role of MAMLD1 in gonadal development is limited, we suggest that additional factors (digenic or oligogenic cause) play a role in the development of complete gonadal dysgenesis in this patient.

Details

Original languageEnglish
Pages (from-to)80-85
Number of pages6
JournalSexual Development
Volume9
Issue number2
Publication statusPublished - 24 Mar 2015
Peer-reviewedYes

External IDs

Scopus 84925455949
PubMed 25660412

Keywords

Keywords

  • Complete gonadal dysgenesis, Disorders of sexual development, MAMLD1